Company announcement – No. 18 / 2022 Interim report for Q1 2022 Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research…
MENLO PARK, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company…
ST. PAUL, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- Pediatric Home Service, PHS, announces today the expansion of its service…
Adoption of SPRINT® PNS System Doubled Within the Last YearCLEVELAND, May 12, 2022 (GLOBE NEWSWIRE) -- Cleveland based medical device…
HALIFAX, Nova Scotia, May 12, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another…
FYARRO net product sales of $2.3 million in partial first quarterDosing of patients initiated in PRECISION 1, a Phase 2 tumor-agnostic…
WARREN, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics…
BERKELEY HEIGHTS, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
HONG KONG, May 12, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing…